Meglumine antimoniate
- Generic Name
- Meglumine antimoniate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C7H18NO8Sb
- CAS Number
- 133-51-7
- Unique Ingredient Identifier
- 75G4TW236W
- Associated Conditions
- -
- Associated Therapies
- -
Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Hospital Universitário Professor Edgard Santos
- Target Recruit Count
- 40
- Registration Number
- NCT00973128
- Locations
- 🇧🇷
Health Post of Corte de Pedra, Valença, Bahia, Brazil
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2010-10-08
- Lead Sponsor
- University of Brasilia
- Target Recruit Count
- 13
- Registration Number
- NCT00818818
- Locations
- 🇧🇷
Health Center Unit of Corte de Pedra, Corte de Pedra, Presidente Tancredo Neves, Bahia State, Brazil
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
- First Posted Date
- 2007-06-18
- Last Posted Date
- 2010-02-17
- Target Recruit Count
- 150
- Registration Number
- NCT00487253
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Combined Military Hospital, Pakistan
- Target Recruit Count
- 400
- Registration Number
- NCT00480883
- Locations
- 🇵🇰
Combined Military Hospital, Kharian Cantonment, Punjab, Pakistan
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
- First Posted Date
- 2006-04-25
- Last Posted Date
- 2009-01-22
- Lead Sponsor
- University of Brasilia
- Target Recruit Count
- 280
- Registration Number
- NCT00317980
- Locations
- 🇧🇷
Núcleo de Medicina Tropical, University of Brasilia, Brasilia, Distrito Federal, Brazil
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-04-25
- Last Posted Date
- 2010-11-24
- Lead Sponsor
- Fundación Cardiovascular de Colombia
- Target Recruit Count
- 178
- Registration Number
- NCT00317629
- Locations
- 🇨🇴
Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Phase 2
Completed
- Conditions
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Target Recruit Count
- 375
- Registration Number
- NCT00004755
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath